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Human umbilical cord blood is an excellent primitive source of noncontroversial stem cells for treatment of hematologic disorders;
meanwhile, new stem cell candidates in the umbilical cord (UC) tissue could provide therapeutic cells for nonhematologic
disorders. We show novel in situ characterization to identify and localize a panel of some markers expressed by mesenchymal
stromal cells (MSCs; CD44, CD105, CD73, CD90) and CD146 in the UC. We describe enzymatic isolation and purification
methods of diﬀerent UC cell populations that do not require manual separation of the vessels and stroma of the coiled, helical-like
UC tissue. Unique quantitation of in situ cell frequency and stromal cell counts upon harvest illustrate the potential to obtain high
numerical yields with these methods. UC stromal cells can diﬀerentiate to the osteogenic and chondrogenic lineages and, under
specific culturing conditions, they exhibit high expandability with unique long-term stability of their phenotype. The remarkable
stability of the phenotype represents a novel finding for human MSCs, from any source, and supports the use of these cells as
highly accessible stromal cells for both basic studies and potentially therapeutic applications such as allogeneic clinical use for
musculoskeletal disorders.
Copyright © 2009 Rebecca C. Schugar et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.

1. Introduction
For years, blood from the UC has been regarded as a
noncontroversial, readily accessible source of hematopoietic
stem and progenitor cells [1–3]. The donation and banking
of UC blood has increased in popularity, providing patients
with a new source of allogeneic donors [4, 5] and accelerating
the identification time of appropriate donors. The presence
of nonblood stem cells from this abundant primitive tissue,
which may be applied for therapies beyond the hematopoietic lineage, may have similar benefits and is attractive to the
field of regenerative medicine. The human UC proper, which

includes the vessels and surrounding connective tissue called
Wharton’s jelly (WJ), may be such a source. During gestation
the human UC develops up to 30–60 cm in length or ∼40–
50 g at birth in order to provide the fetus with nutrient
rich, oxygenated blood, and presumably contains stem and
progenitor cells involved in development.
Here, we performed in situ analysis to determine if cells
expressing MSC markers are present in the full-term UC
(WJ matrix and vessels). Previous reports have described
the isolation of myofibroblasts and endothelial cells from
this tissue [6–9]. Others have described the isolation of cells
which display markers of MSCs at 1–3 weeks postisolation
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(CD90, CD105, CD73, and CD44), using either explant or
enzymatic isolation techniques. However, it has not been
determined if or to what extent stem cells are present in situ,
and if these cells are present at the time of isolation or if the
expressions of MSC markers (many of which have adhesion
related functions [10–12]) are activated postisolation. In
some reports, adherent cells derived from the WJ matrix were
examined for their expression of MSC markers at approximately 7 days postisolation [13–15]; yet, it is not clear if the
various markers were upregulated after culture adherence.
Covas et al. isolated cells from the UC veins and examined
MSC marker expression after 3 weeks of cell culture [16].
Another region of the UC called the perivascular region
which immediately surrounds the vessels and is part of the
WJ matrix, also has been the focus of UC cell isolation
[17, 18]. Recently, Baksh et al. [18] described the diﬀuse
expression of CD146 in the UC vessels and surrounding
perivascular region, and on UC cells approximately 3 weeks
after isolation. CD146 is an endothelial and progenitor cell
marker recently described by some of us [19, 20] and others
[21–24] as a marker of pericytes which may be an origin for
MSCs. However, until now, questions remained as to whether
the MSC-like cells existed in situ in the UC or whether the
MSC markers were upregulated with culture adherence, and
also what may be the optimal method to eﬃciently isolate
such cells from the UC.
In this report, we perform in situ analysis of the entire
cord (WJ matrix and vessels) using several MSC markers
(CD44, CD73, CD90, and CD105) and several progenitor
and endothelial cell markers (CD146, CD34, CD144). We
determine the frequency and location of the markers and
identify various isolation methods which yield diﬀerent cell
types from the whole human UC. We show the isolation
of endothelial cells by certain methods, and we show that
another method that does not require tedious removal of
vessels yields a population which expresses MSC markers and
is capable of multilineage diﬀerentiation. Finally, we identify
a culturing scheme which shows unique quantitative expansion of UC stromal cells (UCSCs) along with remarkable
stability of their marker phenotype.

2. Materials and Methods
2.1. In Situ Analysis. UC tissue was snap frozen in liquid nitrogen-cooled 2-methyl butane and cryosectioned at
10 μm. For histological analysis, sections were fixed in 3%
acetic acid and stained by Alcian Blue (Sigma, St Louis,
MO) and Nuclear Fast Red (Sigma, St Louis, MO). Placental
and fetal ends of the cord were not used, and portions of
tissue within the main UC length were randomly selected
for freezing and analysis. For cell density and phenotype
analysis, sections were fixed in cold 3:1 methanol: acetone
solution and incubated with mouse antihuman primary
antibodies CD34, CD146, CD44, CD73, CD105, and CD90
(BD Biosciences, San Jose, CA) and CD144 (eBioscience, San
Diego, CA) followed by directly coupled secondary antibody
goat antimouse Alexa 488 (Molecular Probes, Carlsbad, CA),
or biotinylated goat antimouse IgG (DAKO, Carpinteria, CA)
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and Streptavidin-Cy3 (Sigma, St Louis, MO) and DAPI. An
isotype-matched negative antibody was used as control.
2.2. Cell Isolation. Full-term male UCs were received, following UC blood removal, from Magee Women’s Hospital
(Pittsburgh, PA) under IRB Number 0606126. Three separate
isolation techniques were employed: (1) mechanical dissociation and explant culture, (2) enzymatic digestion with
dispase, and (3) collagenase digestion. Mechanical dissociation and explant culture: whole UCs were manually dissected
into smaller sections (∼5-6 grams UC tissues per isolation)
and plated in polystyrene tissue culture flasks with serumsupplemented DMEM ((Lonza) with 10% fetal bovine serum
(Gibco, Carlsbad, CA), 10% horse serum (Gibco, Carlsbad,
CA), and 1% Penicillin/Streptomycin (Gibco, Carlsbad, CA)
for 7 days in a 37◦ C, humidified environment with 5%
CO2 . Enzymatic digestion: UCs were manually blunt-cut into
smaller sections, then placed into either dispase (Sigma,
2.4 units/mL) or collagenase type I (Sigma, St Louis, MO,
1 mg/mL in PBS) enzyme, and digested at 37◦ C for 6 hours
with occasional shaking. Following digestion, the isolates
were filtered several times to remove remaining tissue using
a 100 μm pore filter. Cells were placed in culture with fresh
medium for 7 days in a 37◦ C, humidified environment with
5% CO2 . A portion of freshly isolated cells was removed for
flow cytometry analysis and cell enumeration. This portion
was resuspended in 10 mL of RT Erythrocyte lysis buﬀer:
(0.154 M NH4Cl, 10 mM KHCO3, 0.1 mM EDTA; pH =
7.4) for up to 3 minutes before centrifugation, aspiration,
and subsequent resuspension and labeling. Postisolation Cell
Yield: on day 0 of enzymatic isolations, freshly isolated cells
were counted using a hemocytometer. Unlysed anucleate red
blood cells could be visually excluded. Additionally, DAPI
was added to cell suspension to confirm quantification of
nonblood cells only. The total cell yield was determined by
multiplying total cells yielded by digestion divided by the UC
sample weight to arrive at cells/gram ratio. Explant isolated
cells were quantified at day 7–10 postisolation.
2.3. Cell Culture. 7 days postisolation, adherent cells were
removed by trypsin. Following this initial passage, UCSCs
were cultured in proliferation medium, EGM2 (Lonza,
Walkersville, MD), at an initial seeding density of 800
cells/cm2 in polystyrene tissue culture flasks and incubated
in a 37◦ C, humidified environment with 5% CO2 . Routine
cell passaging was performed as above every 3 to 4 days.
2.4. Cell Morphology/Area and Diameter Measurements. Cells
seeded at a density of 800 cells/cm2 in a 24-well plate were
examined over 96 hours using a live automated microscopic
imaging system [25, 26]. Using 30 measurements per UC
sample, we obtained the average 2D monolayer cell area for
all time points to yield a mean cell area for the population.
To determine the mean diameter of the cells, we examine the
cells when they were in a 3D spherical state after replating
and prior to cell adherence. We obtained measurements of 40
cells per UC sample. For both 2D and 3D size measurements,
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Table 1: Physical properties and cell distributions are used to calculate the theoretical cell numbers in each location. Measurements (mean
± st. dev.) are based on fixed, frozen sections and as shown in Figure 1 and Supplemental Table 1.
Parameter
(1) Mean length of human umbilical cord (cm)
(2) Mean diameter of human umbilical cord (cm)
(3) Arterial diameter (μm)
(4) Vein diameter (μm)
(5) Perivascular region, radial distance (thickness, μm)
Potential cell harvest yields
Vessels,
Perivascular regions,
Wharton’s jelly,

we examined n = 3 UC samples isolated with collagenase and
n = 3 UC samples isolated with dispase.
2.5. Flow Cytometry. UCSCs were analyzed for surface
marker expression by flow cytometry (BD FACSCalibur) at
each passage using mouse antihuman antibodies HLA-A,B,C
(MHC-I), HLA-DP, DQ, DR (MHC-II), CD34, CD73, CD90,
CD146 (BD Biosciences, San Jose, CA), CD44, CD105 (Invitrogen, Carlsbad, CA), CD45, and CD144 (eBioscience, San
Diego, CA). Secondary antibodies used as above. Unlabelled
control cells were used to set gates. For comparisons of
cell phenotype by flow cytometry at day 0, seven isolations
were performed side-by-side using dispase or collagenase
methods, and statistical comparisons were performed.
2.6. Proliferation Kinetics and Expansion. For media comparisons, low passage UCSCs were examined by time-lapse
imaging over a 4-day period [25–27]. Cells were plated at 800
cells/cm2 and received either EGM2 or DMEM. Cell counts
were made directly from 10 × images at 12 hours intervals
(n = 3 UCSCs populations). For long-term expansion
assays, cells were cultured in EGM2 media. At passage 1
postisolation, cultures were initiated with 800 cells/cm2 .
After 3-4 days of growth, the cells were trypsinized, counted,
and replated at a density of 800 cells/cm2 . This process was
repeated for more than 10 passages. The hemocytometer
cell counts and cellular dilution factor were recorded at
each passage and used to calculate the expansion potential
or theoretical yield, number of population doublings, and
doubling time [28], n = 13 UCSCs populations expanded
for 10 passages and n = 3 UCSCs populations expanded
for 20 passages. To measure cellular division time (DT) and
the mitotic fraction (or the fraction of daughter cells which
are dividing), during the course of the expansion, cells were
examined via time-lapsed imaging as described above and
elsewhere [25–27].
2.7. Statistical Analysis. For all data sets, normality of data
was first tested using SigmaStat (Kolmogorov-Smirnov test,
Jandel Scientific). Parametric or nonparametric ANOVA
analysis was performed, with 2-tailed significance set at P <
.05. Mean and standard deviation or error and n are reported
for each analysis.

Measurement
30–60
1.3 ± 0.25
2040 ± 66
3550 ± 190
4230 ± 120
Theoretical Total Number of Cells per gram
Theoretical Total Number of Cells per gram
Theoretical Total Number of Cells per gram

8.1–8.9 × 106
∼1 × 106
1.3–1.4 × 106

3. Results
3.1. In Situ Detection of Mesenchymal Markers in Umbilical
Cord Tissue. Human UC (Figure 1(a)) sections were analyzed by histology and immunohistochemistry. Histostaining
with Alcian blue clearly distinguishes the vascular regions
from the WJ matrix and epithelium (Figure 1(b) and see
Figure 1 in Supplementary Material available online at
doi:10.1155/2009/789526). Cellular density decreases progressively from the vascular regions to the first 400-micron
radial region surrounding the vessels and which constitutes
the perivascular area of the matrix and finally to the outer
regions of the WJ matrix tissue, which has the lowest cell
density. In situ characterization of mesenchymal marker
expression in the UC has not been previously described.
Tissue was immunostained to detect (hematopoietic) stem
cell marker and endothelial marker CD34, endothelial cell
markers CD144 and CD146, and MSC markers CD44,
CD105, CD73, and CD90 (Figure 1(d)) and the percentage of
cells expressing these markers was quantified (Figure 1(e)).
We detected CD34 and CD144 in the endothelial lumen
lining of the vessels, but not in other regions of the UC.
We observed CD146 expression in the vessel walls (100%)
and perivascular region of the WJ (62%). Expression patterns
for CD44 and CD105 were similar; positive cells were found
in the vessels (∼2.5%) and in the perivascular (7%–14%)
and outermost regions of WJ matrix (12%). CD105 also
was expressed notably in the endothelial lumen lining. CD73
expression is found throughout the vessels and endothelium,
albeit low intensity, absent in the perivascular region, and
highest in the epithelium and subepithelial regions of the WJ
matrix (75%). CD90 positivity was detected in most regions
(>90%) but absent in the endothelial lumen lining. Previous
reports have described neither the in situ localization of cells
expressing these mesenchymal markers nor their presence on
UC cells immediately following isolation (Figure 2).
3.2. High Cell Yields of MSC Cells from the Primitive Cell
Source. We estimated the theoretical number of cells per
gram of UC tissue by (1) analyzing the double-stranded
DNA (dsDNA) content and (2) examining in situ cell density
and models of cell packing. Standard curves estimated about
16.1 pg dsDNA per cell, and 1.9 × 105 ng dsDNA per gram

4

Journal of Biomedicine and Biotechnology

Endothelium Lumen
Vein

WJ

Epithelium

(a)
Vessel
Vessel

WJ

WJ

Artery
Perivascular region

WJ

(b)

(c)

Artery

Artery
PV

Endothelium
CD34

Endothelium
CD144

Artery

CD146

Artery

CD44

Artery

Artery

CD105

Artery

CD146

CD73

Artery

CD90
Artery
PV

Epithelium
CD44

CD105

Lumen

CD73

Artery
wall

CD90
Wharton’s Jelly

Artery
wall

Epithelium
Lumen

CD44

CD105

CD73

CD90

Marker positive (%)

(d)
100
75
50
25
0
CD34 CD144 CD146 CD44 CD105 CD73

CD90

Wharton’s Jelly

0

0

0

12

12

75∗

Perivascular region

0

0

62

7

14

0

96

Vessels

0

0

100

3

3

100

100

100

100

0

0

100

100

0

Lumen endothelium

91

(e)

Figure 1: In situ examination of human umbilical cords. (a) UCs range in length up to 60 cm; shown is a cut 10 cm portion with UC blood
removed. (b) Histology of 10 micron thick cryosections stained with Alcian blue. (c) Schematic of UC cross-section. Green dots represent
cells; all other structures are as indicated. (d) Detection of CD34, CD144, CD146, CD44, CD105, CD73, and CD90. CD34 and CD144 are
expressed only in the endothelial lumen of the UC vessels. CD146 expression is present in both the vascular and perivascular regions, but not
in the bulk of the WJ. CD44- and CD105-positive cells are found in the WJ, perivascular region, and in the vessels. CD105 is also in the lumen.
A low level of CD73 expression is found throughout the vessels and high in the region just beneath the epithelium (∗ 75% positivity only in
the region just below epithelium). CD90 positivity was detected in all regions, except the endothelium. Scale bars on whole vessel images
represent 200 μm; all others represent 100 μm. (e) The percentage of cells expressing these markers was determined by immunostaining: (PV:
perivascular region).

Journal of Biomedicine and Biotechnology

5
Perivascular
9%
WJ
12%

1

Theoretical and total cell counts
after isolation per gram UC tissue

1.3E + 07

10–11 million
cells/gram
2

3
4

5

Vessels
79%
5.0E + 05

Theoretical Explants Collagenase Diapase
yield
(day 10)
(day 0)
(day 0)
1.3E + 07 1.75E + 05 5.3E + 05 5.1E + 04

(a)

(b)
Population phenotype on day 0 of isolation
∗

Dispase isolated

∗

∗

CD90

CD73

CD105

CD44

0
CD146

17.7 ± 2.3 μm

∗

25

CD144

17.1 ± 0.7 μm

∗

50

CD34

Dispase
3368 ± 567 μm2

∗

75

CD45

Collagenase
1628 ± 76 μm2

∗

MHC1

Collagenase isolated

Monolayer area
Diameter,
in suspension

Expression of DAPI [+]
cells (%)

100

Collagenase
Dispase
(c)
Population phenotype at week 1
postisolation

120

∗

100
80
60

∗

∗

∗

40
20
0
CD45

CD34

CD144

Collagenase
Dispase
(e)

CD146

CD90

Population phenotype at week 3
postisolation

120
Population expression (%)

Population expression (%)

(d)

∗

∗

∗

100
80
60
40
20
0
CD45

CD34

Collagenase
Dispase

CD144

CD146

CD90

(f)

Figure 2: Tissue processing and method of isolation aﬀect total cell yield and population phenotype. (a) Physical properties of the UC
tissue provide an estimate that 10-11 million cells per gram can be isolated from the tissue (also see Table 1 and Table 1 in Supplementary
Material available online at doi:10.1155/2009/789526). (b) The theoretical yield of 10-11 million cells/UC gram includes 79% vascular cells,
9% perivascular cells, and 12% WJ cells. Distinct phenotypes based on enzymatic method are evident by both morphology (c) and molecular
phenotype (d)–(f). (c) Cell area or spreading in 2D monolayer is significantly larger for dispase-isolated cells versus collagenase-isolated cells
(mean ± s.e.m., P < .001), although the cells have similar diameter or size when measured prior to surface adhesion. (d) Mean surface marker
expression on day 0 of isolation. Collagenase-isolated cell populations have a significantly higher level of expression of CD44 (P = .005),
CD105 (P = .014), and CD90 (P < .001), as compared to dispase-isolated cells that exhibit a significantly higher level of endothelial marker
expression, CD34 (P < .001), CD144 (P < .001), and CD146 (P = .049), and CD73 (P < .001) which was also detected in the endothelium. (e)
Marker expression at week 1 postisolation. Significant diﬀerences were detected for expression of CD45 (P = .01), CD34 (P < .001), CD144
(P = .006), and CD90 (P = .003). (f) Marker expression at week 3 postisolation. Significant diﬀerences were detected for expression of CD144
(P = .017), CD146 (P = .008), and CD90 (P = .001). The use of collagenase enzyme yields a cell population with significantly higher MSC
marker expression levels in comparison to both dispase enzyme digestion and mechanical dissociation.The latter two methods, however,
yield populations with significantly higher endothelial cell marker expression levels than the collagenase enzyme digest.
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tissue (Supplementary Figure 1). Together, this estimates
11.7 ± 2.7 × 106 cells per gram of UC tissue. This value is
consistent with calculations based of a numerical method, in
which the mean cell-cell distance is used along with physical
properties of full-term UCs and particle packing models to
determine the number of cells or particles in a given volume.
With the numerical method, we estimated the theoretical
yield of cells that could be obtained utilizing a fully optimized
isolation procedure to be 10-11 million cells per gram of UC
tissue (Table 1 and Supplementary Table 1); this is in close
agreement to the estimate by DNA analysis. The numerical
method can also provide estimates in the diﬀerent regions:
8-9 × 106 cells per UC gram in the vessels (79%), ∼1 × 106
cells per gram in the perivascular region (9%), and ∼1.5 ×
106 cells per gram in the WJ matrix (12%, Figures 2(a) and
2(b)).
Cell isolation and processing techniques can aﬀect the
number and phenotype of isolated cells, both of which are
critical to cell-based therapeutics [29, 30]. To investigate
which isolation method yields the greatest number of UCderived cells which express MSC markers, we examined 3
isolation methods: (1) mechanical dissociation and explant
culture, (2) enzymatic digestion with dispase, and (3)
collagenase digestion (n = 3 each). Collagenase digest yielded
5.3 ± 1.5 × 105 cells per gram of digested UC tissue; in
comparison, we observed that the dispase digest resulted
in a 10 times lower cell yield of 5.1 ± 3.4 × 104 cells per
gram (Figure 2(b)). Cells derived by the mechanical dissociation and explant culture technique required 7–10 days
in culture for suﬃcient cellular emigration; in the highest
yield, we isolated 1.75 × 105 total cells per gram by day 10
(Figure 2(b)), although cellular divisions occurring during
this period confound the actual cell isolation counts. For
these reasons, explant isolations were not explored further,
and subsequent comparisons were made between dispase
and collagenase isolated cells. Morphological diﬀerences
were apparent between these populations; cells isolated from
either the collagenase method or dispase method had similar
size (diameters = 17.1 μm and 17.7 μm, resp., P > .05) when
measured as nonadhered round spherical cells. However,
dispase digestion yielded cells with a noticeable endothelial
morphology and a significantly larger area of spreading in
monolayer as compared to cells obtained from collagenase
digestion (monolayer 2D area 3390 μm versus 1630 μm, resp.,
P < .05, Figure 2(c)).
We determined that cells expressing surface markers of
MSCs could be identified at the time of isolation, and distinct
cell populations could be obtained based on surface marker
expression (day 0, Figure 2(d)) following the initial isolation
period and according to the method of isolation. In sideby-side analysis, we compared the marker profiles from cells
obtained from dispase isolations (n = 7) and collagenase
isolations (n = 8) on day 0. Cells were analyzed for surface
marker expression of MHC-I and MHC-II antigens, CD45,
CD34, CD144, CD146, CD44, CD105, CD73, and CD90.
UC cells isolated by the collagenase method showed a
significantly higher level of MSC marker expression at day
0—CD44, CD105, and CD90 expressions were higher in this
UC population as compared to cells isolated using dispase
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(P = .034, P = .014 and P < .001 resp.). On the contrary,
dispase-isolated cells expressed significantly higher levels of
the endothelial markers CD34 and CD144 on the day of
isolation (both P < .001). On the day of isolation, the
dispase-isolated cells also showed a higher level of expression
of CD146 as compared to collagenase-isolated cells (38 ±
18% versus 16.6 ± 9.4%, P = .050). Finally, in comparison
to the collagenase-isolated cells, the dispase-isolated cells
showed higher expression levels of CD73, which was detected
in situ in both the endothelium and the subepithelial region
of the WJ. In sum, at the time of isolation, cells derived
from the whole UC using collagenase expressed high levels
of MSC markers and low levels of endothelial markers, while
the dispase-isolated cells expressed low levels of most MSC
markers and high levels of endothelial markers.
The diﬀerences in the 2 UC-derived populations persisted after growth in culture for 1 and 3 weeks. In comparison to dispase-isolated cells, the collagenase digestion
yielded a population with significantly more CD90 at week
1 and week 3 (>95%, Figures 2(e) and 2(f)). These cells
continued to have low levels of CD34 (absent) and CD144
(5.0% at week 1 and 0.7% at week 3 Figures 2(e) and 2(f)).
UC cells isolated with collagenase showed moderate levels of
CD146 (48%; week 1, and 42%; week 3, Figures 2(e) and
2(f)). Consistent with their endothelial morphology, dispaseisolated cells expressed higher levels of CD34 and CD144,
at week 1 (P < .001 and P = .006, resp.), and CD144, at
week 3, as compared to the collagenase-isolated population
(P = .017, Figures 2(e) and 2(f)). Dispase-isolated cells
exhibited lower level expression of CD90 at both week 1
(4%, P = .003) and week 3 postisolation (6.6%, P = .001,
Figures 2(e) and 2(f)). Dispase-isolated cells also expressed
high levels of CD146 (week 1: 82%, P > .05 and week 3:
99%, P = .008). The explant isolation, like dispase isolation,
yielded cells that were high in both CD144 (38%) and CD146
(68%) and low in MSC marker CD90 (4%). Finally, both
collagenase and dispase populations show a rapid increase in
expression levels of CD73, CD105, and CD44 during the first
few weeks of culture during which time levels reach >95% in
all cases. This rapid increase may be a result of the presence
of cells analyzed on day 0 that have been stripped of their
surface markers following extensive enzyme treatment. On
the other hand, it is not surprising to see an increase in these
markers in culture, as in addition to being characteristic of
MSCs, these surface markers are also well known as both
cell adhesion and signaling molecules [10–12]. Thus it is
important to note that CD73, CD105, and CD44 are just a
few of numerous markers shown to be present on MSCs,
and as described below, despite their presence on the dispaseisolated cells, these markers alone are not suﬃcient to confer
multipotentiality.
Therefore, we have determined that the collagenase
digestion process will consistently isolate a specific cell
population expressing MSC surface markers and CD146, but
not endothelial markers (CD44+/CD73+/CD105+/CD90+
and CD14650% and CD144–), when compared to the
dispase digest and mechanical dissociation/explant culture
methods (CD44+/CD73+/CD105+/CD90– and CD146100%
and CD144+). Furthermore, while the cells isolated by the
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dispase method show an increase in expression of CD44,
CD73, and CD105, but not CD90, after cell culture, these
cells continue to highly express CD144 and CD146. Together
these markers (CD144 and CD146) suggest an endothelial
phenotype (Supplementary Figure 2(a)). On the other hand,
collagenase-isolated cells maintain high expression of this
panel of MSC markers and moderate but steady levels of
CD146. Additionally, these cells do not express endothelial
marker CD144 at any point through 35 days of passaging.
While the role of CD146 on mesenchymal-like cells has
yet to be determined [23, 24, 31, 32], Baksh reported
similar expression levels for UC perivascular cells [18]. Also,
we performed fluorescence-activated cell sorting (FACS) to
purify for a fraction of collagenase-isolated cells which were
>98% positive for CD146; however, within 48 hours, the
population reverted to ∼50% CD146 positive. Therefore, for
the remainder of the experiments, we studied the UC cells
derived by the collagenase and dispase methods as opposed
to FACS-purified cells.
3.3. UCSCs Multipotency. To examine multipotency, we
performed side-by-side examination of the osteogenic
and chondrogenic diﬀerentiation capabilities of these 2
populations—MSC-like cells (CD90+/CD144–/CD14650% )
isolated by the collagenase method and endothelial-like cells
(CD90–/CD144+/CD146100% ) isolated by dispase method.
We detected increased presence of alkaline phosphatase in
collagenase-isolated cells induced with bone morphogenic
protein-4 (BMP4) as compared to the nonstimulated controls, and in comparison to day 1 controls (P = .04, t-test,
-BMP4 versus +BMP4 day 7). The dispase-isolated cells did
not express detectable levels of alkaline phosphatase either at
baseline or after BMP4 stimulation (Supplementary Figures
3(a) and 3(b)). The collagenase-isolated cells also exhibited
chondrogenic potential through the use of the classic pellet
assay. Cells were treated with chondrogenic medium containing TGF-β1. By day 10, the pellet constructs showed
increased proteoglycan content, increased collagen content,
the morphological appearance of lacunae, and a quantified
increase in extracellular matrix deposition (ECM) at day 10
as compared to day 1 (Supplementary Figures 3(c) and 3(d)).
In all attempts, the dispase-isolated endothelial-like cells
failed to form pellets or high-density aggregates in the chondrogenic assay (n = 3 UC samples, 20 attempted runs total).
Based on the marker expression and the multipotent
diﬀerentiation capacity of the cells isolated by the collagenase method (CD44+/CD73+/CD90+/CD105+/CD144–
/CD14650% ), we term these cells multipotent UC stromal
cells, UCSCs. By comparison, the dispase isolation method
selectively purifies for a population of CD146+ endothelial
cells (CD90–/CD144+/CD146100% ). Based on the clear lack
of multipotency in the dispase-isolated cells (albeit they were
CD105+/CD44+/CD73+) our subsequent studies focused on
the UCSCs which showed multipotent activity.
3.4. UCSCs have Long-Term In Vitro Self-Renewal, High
Expandability, and Phenotype Stability. To further support
the progenitor cell nature of the UCSCs, we next tested
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their long-term in vitro self-renewal and phenotypic stability during ex vivo expansion. We first found that the
cells showed a significantly higher level of proliferation in
EGM2 growth medium as compared to serum-supplemented
DMEM (population doubling time, PDT, for UCSCs in
EGM2 = 18 ± 1.0 hours, versus PDT for DMEM = 43 ±
13 hours Figure 3(a)), which is the most frequently used
media for culturing various UC populations [14, 17, 18, 33,
34]. Furthermore, cells grown in DMEM exhibit a distinct
morphology and have significantly greater 2D monolayer cell
spreading as compared to cells grown in EGM2 (Figure 3(b)).
We observed significantly more CD146 expression on UCSCs
grown in DMEM as compared to EGM2 (62 ± 12 versus 28 ±
11, P < .01). However there was no diﬀerence in expression of
CD44, CD73, CD90, and CD105 (Supplementary Figure 4).
Thus, we determined EGM2 to be a preferable proliferation
medium for the UCSCs. In fact, we were able to expand
UCSCs for more than 55 population doublings (PDs) after
22 passages, or 70 days in culture (Figure 3(c)), and we
could obtain a theoretical yield of >1021 cells from an
initial seeding density of 2 × 104 cells. We expanded
13 populations through 10 passages, and 3 of these UC
populations were continued for an additional 10 passages.
While the populations continued to be viable, the assays were
ended at this time. The mean population doubling time of
the UCSCs was 24 ± 1.1 hours (mean ± standard error) for
cells at 0–10 PDs, 23 ± 1.7 hours at 10–20 PDs, which are
significantly faster (P = .02 and P = .02, resp.,) than the PDT
of 28 ± 1.3 hours at 20–30 PDs (Figure 3(d)). We observed
no significant changes in cellular division times (Figure 3(e))
for cells at 0–10 PDs (14.8 ± 0.4 hours), 10–20 PDs (15.1 ±
0.7 hours), and 20–30 PDs (15.9 ± 0.8 hours). The mitotic
fraction, or fraction of actively dividing cells, within the
UCSC populations was 80%–88% of cells at 0–20 PDs, which
is significantly higher than the mitotic fraction of cells at
20–30 PDs, which was 60 ± 7% (mean ± s.e.m., data not
shown). Dispase-isolated cells showed slower growth rates
with a mean PDT = 27.3 hours through the course of 10
passages (shown earlier in Supplementary Figure 2(b)).
Flow cytomety histograms (Figure 3(f)) demonstrate
that the population is homogeneously positive for MHC-I
(95 ±1.7%), CD44 (98 ± 0.7%), CD73 (97 ± 0.6%), CD90
(98 ± 0.7%), and CD105 (97 ± 0.6%), and negative for
MHC-II (0.6 ± 0.1%), CD34 (0.73 ± 0.50%), CD45 (0.5
± 0.3%), and CD144 (1.6 ± 0.7%) at the onset of in vitro
expansion. The population also shows positivity for CD146
(53 ± 18%). The UCSCs were continuously expanded in
culture for a minimum of 10 passages, or approximately
35 days (Figure 3(g)). The UCSCs retain MHC-I positivity
and MHC-II negativity (data not shown), remain negative
for CD34, CD45, and CD144, and exhibit a consistent
CD146 expression level of approximately 50% throughout
culture expansion. At each passage, the UCSC population
is consistently highly positive (≥97%) for all MSC markers
analyzed. PCR analysis of low-passage and high-passage cells
confirmed the presence of mRNA transcripts corresponding
to the MSC markers (Figure 3(h)). This remarkable stability
of the UCSCs phenotype represents a novel finding for
mesenchymal stromal cells, from any source.
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Figure 3: UCSCs demonstrate a high level of ex vivo expansion and retain MSC surface marker phenotype for up to 10 passages, or 5 weeks
in culture. (a) UCSCs showed a significantly higher level of proliferation in EGM2 growth medium as compared to DMEM (72 hours, P
= .038, 96 hours, P = .10). (b) Cells cultured in the diﬀerent media were distinct morphologically; DMEM-cultured cells were significantly
larger in 2D as compared to cells grown in EGM2 (mean ± s.e.m.). (c) We expanded UCSCs for more than 55 population doublings, PDs.
Thirteen UCSC populations were expanded for 10 passages, and 3 of these UCSC populations were continued for another 10 passages. The
theoretical expansion yield is 1020 cells from an initial 2 × 104 cells. (d) Mean population doubling time of the UCSCs was 24 ± 1.1 hours
for the populations at 0–10 PDs, 23 ± 1.7 hours at 10–20 PDs, which are significantly faster than the PDT of 28 ± 1.3 hours for UCSCs at
20–30 PDs (P < .05, bars represent mean ± s.e.m.). (e) We observed no significant changes in cellular division times which was similar for
cells at 0–10 PDs (14.8 ± 0.4 hours), 10–20 PDs (15.1 ± 0.7 hours), and 20–30 PDs (15.9 ± 0.8 hours). (f) Histograms are representative
of UCSCs surface marker expression 7 days postisolation. The population is homogeneously positive for mesenchymal cell markers CD44,
CD105, CD73, and CD90, and ∼50% positive for endothelial cell marker CD146, and negative for hematopoietic cell markers CD34 and
CD45, and endothelial cell marker CD144. (g) Surface marker expression levels through 10 passages. UCSCs have steady but moderate
CD146 expression levels and remain negative for CD45, CD34, and CD144 expression. The cells are consistently highly positive (≥97%) for
all mesenchymal markers analyzed throughout the five-week period and support the reproducibility of the isolation method and stability
of the MSC-like phenotype. (h) Representative PCR analysis of low-passage and high-passage UCScs confirmed the presence of mRNA
transcripts for MSC genes. Lane 1: UCSCs at passage 2; Lane 2: UCSCs at passage 8; Lane 3: human vascular endothelial cells (HUVEC);
Lane 4: no DNA.

4. Discussion
The therapeutic potential of cells expressing MSC markers
is well described in terms of tissue repair [35, 36], and
more recently, immunoprotection [37, 38]. We show for the
first time that cells expressing mesenchymal markers CD44,
CD105, CD73, and CD90 are present in situ in both the WJ
and UC vessels. We also show that the UCSCs express these
markers at the time of isolation from the whole UC, and that
this method can generate large numbers of cells at the time of
isolation. These cells are multipotent, as previously described
for other UC-derived cells [13, 18, 39] and can undergo longterm expansion in culture as shown here. The UC could be an
excellent postnatal, yet primitive, tissue source to yield high
numbers of stromal cells of consistent donor age for both
basic studies and cell technologies in regenerative medicine.
We report here that the UC contains, by conservative
estimate, approximately 11 million cells per gram of tissue,
and the average cord is 40 grams. We were able to obtain
approximately 5.3 × 105 cells per gram of digested tissue.
Although few reports describe isolation yields, this yield is
higher than previous reports using diﬀerent isolation and
processing methods [14, 17]. If the entire length of the UC

were digested using the process described here, we estimate
that 21 million cells could be isolated on day 0. Further
optimization is possible since the entire cord contains a
theoretical yield of 500 million cells. These numbers suggest a
viable, plenteous source of cells, which overcomes challenges
of other adult-derived sources including limited control
of harvest yields, donor age, and sex. Various methods
have been used to isolate diﬀerent cell types from the
UC [13, 14, 17, 18, 33] including myofibroblasts and
endothelial cells [6–9]. We show that the isolation method
aﬀects population phenotype. While some reports describe
cell isolation following UC dissection, we found that a
collagenase-based digestion applied to the whole UC will
consistently isolate a specific cell population expressing
high levels of MSC surface markers and moderate levels of
CD146 (40%–50%). These cells also were negative for MHCII allowing for potential increased immunocompatability
during allogeneic transplantation. Conversely, mechanical
dissociation and explant culture and digestion by dispase
yield cell populations high in endothelial markers CD144
and CD146 (100%). The expression of CD146 on endothelial
cells is well documented and we suspect that the cells
identified here as expressing both CD144 and CD146 are
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likely diﬀerentiated endothelial cells as they also showed
no multipotent diﬀerentiation activity. However, nonendothelial cell populations expressing CD146 have recently
come to light. Crisan et al. identified cell populations in
numerous tissue sources that expressed CD146, an array of
MSC markers, and were negative for endothelial markers
including CD144 [19]. The findings supported the notion
that CD146+ pericytes are indeed MSC precursors. In this
report, UCSCs demonstrate a moderate but consistent level
of CD146 expression (40%–50%) in the population, which
was re-established within 5 days after FACS purification to
a nearly 100% CD146 population. This level of expression
was also reported by the group of Baksh et al. [18] in a
study of perivascular and bone marrow MSCs. Additionally,
Sorrentino et al. used CD146 as a marker to extract multipotent MSCs from the heterogeneous mononuclear cells of
the bone marrow [24]. Here, we identify that UC digestion
by collagenase selects against hematopoietic and endothelial
cells and maximizes yield of cells expressing both CD146 and
MSC markers. Importantly, this method does not require
removal of the vessels and therefore reduces the time and cost
of UCSCs extraction, while optimizing yield of the desired
phenotype.
In addition to harvest yield, stem cell therapeutics using
UCSCs will depend on ex vivo expandability and maintenance of desired phenotype. UCSCs can undergo extensive
in vitro self-renewal, with some populations reaching 55 PDs
(PDT = 24 hours). This high level of UCSCs’ expandability is
conducive to cell banking. Other reports of cumulative PDs
and PDTs show slower growth rates (PDT = 34–38 hours)
that may be due to phenotypic diﬀerences or culture condition diﬀerences. Explanted UC CD105[+] cells of Conconi et
al. [15] underwent 30 PDs in approximately 48 days (PDT∼
38 hours), while UC perivascular cells underwent 21 PDs in
30 days (PDT ∼34 hours) [17] and sometimes slower rates
[18]. It is interesting that these studies used DMEM [18] or
a-MEM [15, 17] for growth media. We found that the use
of EGM2, as we compared here to DMEM, contributes to a
significant diﬀerence in growth rates.
Furthermore, expansion limits associated with loss of
phenotype and low proliferative potential, which would not
be uncommon in human cell populations, did not occur
here. In fact, we observed a high level of phenotype stability
in cells that were maintained at a controlled cell density
in EGM2 medium. While EGM2 medium is traditionally
viewed as an endothelial medium, as it includes vascular
endothelial growth factor, we do not observe an increase in
any of the endothelial markers (CD34, CD144, or CD146);
rather there is remarkable stability and maintenance of the
population phenotype.
Reliable access to tissue of consistent age and sex, such
as the human UC, makes these cells amenable to cell
technologies. Here we showed the targeted isolation and
subsequent purification of UCSCs in high yield, with
high expansion potential. The remarkable stability of the
phenotype represents a novel finding for MSCs, from any
human source, and supports the use of these human cells
as highly accessible stromal cells for both basic studies and
clinical use.
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